We know that Anavex has a drug distributor in AU that handles the distribution of 2-73 for the SAS and presumably for the trials.
I don't know what information the distributor has on the people that receive the drug. Maybe the distributor just gets requests from a pharmacy and the AU equivalent of HIPPA prevents the pharmacy from disclosing the information to the distributor.